Profound Medical Corp Stock Performance
| PROF Stock | USD 7.63 0.75 8.95% |
On a scale of 0 to 100, Profound Medical holds a performance score of 15. The company holds a Beta of 2.22, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Profound Medical will likely underperform. Please check Profound Medical's value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Profound Medical's historical price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Profound Medical Corp are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent basic indicators, Profound Medical reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (3.12) | Five Day Return 2.07 | Year To Date Return 9.4 | Ten Year Return (13.70) | All Time Return (13.70) |
Last Split Factor 1:10 | Dividend Date 2019-10-16 | Last Split Date 2019-10-16 |
1 | Why retail investors favor Profound Medical Corp. stock - July 2025 Intraday Action Free Fast Gain Swing Trade Alerts - newser.com | 10/29/2025 |
2 | Profound Medical Upgraded to Buy What Does It Mean for the Stock | 11/19/2025 |
3 | Profound Medical Just Flashed Golden Cross Signal Do You Buy | 11/24/2025 |
4 | Wall Street Analysts Think Profound Medical Could Surge 82.37 percent Read This Before Placing a Bet | 12/05/2025 |
5 | How To Trade - news.stocktradersdaily.com | 12/17/2025 |
6 | Profound Medical Corp. Announces Pricing of up to 40 Million Financing Comprised of a 36 Million Registered Direct Offering and a Subsequent 4 Million Private P... | 12/19/2025 |
7 | Insider Spends US139k Buying More Shares In Profound Medical - Yahoo Finance Australia | 12/31/2025 |
8 | Johns Hopkins Medicine Treats First Commercial TULSA-PRO Case | 01/06/2026 |
9 | Profound Surpasses 2025 TULSA-PRO Installed Base Goal | 01/12/2026 |
Profound Medical Relative Risk vs. Return Landscape
If you would invest 556.00 in Profound Medical Corp on October 16, 2025 and sell it today you would earn a total of 282.00 from holding Profound Medical Corp or generate 50.72% return on investment over 90 days. Profound Medical Corp is currently generating 0.7425% in daily expected returns and assumes 3.76% risk (volatility on return distribution) over the 90 days horizon. In different words, 33% of stocks are less volatile than Profound, and 86% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Profound Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Profound Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Profound Medical Corp, and traders can use it to determine the average amount a Profound Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1975
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PROF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Profound Medical is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Profound Medical by adding it to a well-diversified portfolio.
Profound Medical Fundamentals Growth
Profound Stock prices reflect investors' perceptions of the future prospects and financial health of Profound Medical, and Profound Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Profound Stock performance.
| Return On Equity | -1.24 | ||||
| Return On Asset | -0.62 | ||||
| Profit Margin | (2.75) % | ||||
| Operating Margin | (1.69) % | ||||
| Current Valuation | 295.78 M | ||||
| Shares Outstanding | 36.29 M | ||||
| Price To Book | 9.77 X | ||||
| Price To Sales | 21.96 X | ||||
| Revenue | 10.17 M | ||||
| Gross Profit | 10.36 M | ||||
| EBITDA | (25.59 M) | ||||
| Net Income | (27.82 M) | ||||
| Cash And Equivalents | 46.21 M | ||||
| Cash Per Share | 2.21 X | ||||
| Total Debt | 5.12 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 17.36 X | ||||
| Book Value Per Share | 1.06 X | ||||
| Cash Flow From Operations | (23.45 M) | ||||
| Earnings Per Share | (1.32) X | ||||
| Market Capitalization | 313.93 M | ||||
| Total Asset | 70.23 M | ||||
| Retained Earnings | (245.17 M) | ||||
| Working Capital | 62.5 M | ||||
| Current Asset | 9 K | ||||
| Current Liabilities | 761 K | ||||
About Profound Medical Performance
By analyzing Profound Medical's fundamental ratios, stakeholders can gain valuable insights into Profound Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Profound Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Profound Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 523.09 | 458.88 | |
| Return On Tangible Assets | (0.36) | (0.38) | |
| Return On Capital Employed | (0.47) | (0.49) | |
| Return On Assets | (0.36) | (0.37) | |
| Return On Equity | (0.41) | (0.44) |
Things to note about Profound Medical Corp performance evaluation
Checking the ongoing alerts about Profound Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Profound Medical Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Profound Medical appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 10.17 M. Net Loss for the year was (27.82 M) with profit before overhead, payroll, taxes, and interest of 10.36 M. | |
| Profound Medical Corp currently holds about 46.21 M in cash with (23.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.21. | |
| Profound Medical has a very weak financial position based on the latest SEC disclosures | |
| Latest headline from globenewswire.com: Profound Surpasses 2025 TULSA-PRO Installed Base Goal |
- Analyzing Profound Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Profound Medical's stock is overvalued or undervalued compared to its peers.
- Examining Profound Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Profound Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Profound Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Profound Medical's stock. These opinions can provide insight into Profound Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Profound Stock analysis
When running Profound Medical's price analysis, check to measure Profound Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profound Medical is operating at the current time. Most of Profound Medical's value examination focuses on studying past and present price action to predict the probability of Profound Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profound Medical's price. Additionally, you may evaluate how the addition of Profound Medical to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |